Relmada Therapeutics, Inc. (RLMD)
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
$105.61M
Dr. Sergio Traversa M.B.A., MBA, Pharm.D., PharmD
10.00
Coral Gables, FL
Mar 03, 2014
-1.22
$-2.87
1.35
11.40
0.00%
-0.70
-0.17
0.79
0.00
11.07
-104.13%
-93.51%
Similar stocks (12)
Revolution Medicines, Inc.
RVMD
Cytokinetics, Incorporated
CYTK
Dyne Therapeutics, Inc.
DYN
Edgewise Therapeutics, Inc.
EWTX
Nuvation Bio Inc.
NUVB
Third Harmonic Bio, Inc.
THRD
Eliem Therapeutics, Inc.
ELYM
Shattuck Labs, Inc.
STTK
Century Therapeutics, Inc.
IPSC
PMV Pharmaceuticals, Inc.
PMVP
RAPT Therapeutics, Inc.
RAPT
Champions Oncology, Inc.
CSBR
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.0153%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.1820000000000001e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
Revolution Medicines, Inc.
RVMD
Cytokinetics, Incorporated
CYTK
Dyne Therapeutics, Inc.
DYN
Edgewise Therapeutics, Inc.
EWTX
Nuvation Bio Inc.
NUVB
Third Harmonic Bio, Inc.
THRD
Eliem Therapeutics, Inc.
ELYM
Shattuck Labs, Inc.
STTK
Century Therapeutics, Inc.
IPSC
PMV Pharmaceuticals, Inc.
PMVP
RAPT Therapeutics, Inc.
RAPT
Champions Oncology, Inc.
CSBR
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.0153%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.1820000000000001e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%